Anzeige
Mehr »
Login
Dienstag, 04.03.2025 Börsentäglich über 12.000 News von 689 internationalen Medien
Trumps Krypto-Reserve löst Markt-Explosion aus - Pioneer AI Foundry setzt auf Solana!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40GEB | ISIN: US67079U3068 | Ticker-Symbol:
NASDAQ
03.03.25
21:44 Uhr
50,61 US-Dollar
-4,29
-7,81 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NUTEX HEALTH INC Chart 1 Jahr
5-Tage-Chart
NUTEX HEALTH INC 5-Tage-Chart

Aktueller Chart NUTEX HEALTH Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
NUTEX HEALTH INC-Investoren interessieren sich auch für diese Wertpapiere
EQS-News: Immunic AG: Immunic to Participate in Scientific and Investor Conferences in MarchIssuer: Immunic AG / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in March 03.03.2025 / 12:30 CET/CEST The issuer is solely...
► Artikel lesen
EQS-News: Immunic AG: Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple SclerosisIssuer: Immunic AG / Key word(s): Conference/Study Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025, Highlighting Its Potential in Multiple Sclerosis 26.02.2025...
► Artikel lesen
EQS-News: Immunic AG: Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical TestingIssuer: Immunic AG / Key word(s): Study results Immunic's Oral IMU-856 Demonstrated Dose-Dependent Increase of GLP-1 in Celiac Disease Patients and Corresponding Effects in Preclinical...
► Artikel lesen
Applied DNA Sciences, Inc.: Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress- Announces Exit of DNA Tagging and Security Products and Services Business Segment -- Workforce Reduction of 20% of Headcount Implemented in January -- GMP Site 1 Facility Complete and Certified for...
► Artikel lesen
Applied DNA Sciences, Inc.: Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025Investor Call and Webcast Scheduled for 4:30 P.M ET STONY BROOK, NY / ACCESS Newswire / February 12, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase...
► Artikel lesen
Applied DNA Sciences, Inc.: Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14STONY BROOK, NY / ACCESS Newswire / February 11, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today issued a reminder to...
► Artikel lesen
Xeriant, Inc. Provides Update on Litigation Against XTI Aircraft Co.BOCA RATON, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI), an aerospace technology company dedicated to the development and commercialization of advanced materials, announces...
► Artikel lesen
XTI Aerospace, Inc.: XTI Aerospace to Acquire Equity Interest in ReadyMonitor AI-Powered, Autonomous Drone CompanyThe Future of Drones is Fully Autonomous ENGLEWOOD, Colo., Jan. 13, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI" or the "Company"), a pioneer...
► Artikel lesen
XFRA N2T: AUSSETZUNG/SUSPENSIONDAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXTI AEROSPACE INC....
► Artikel lesen